Alvotech (ALVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALVO | AMGN | VRTX | REGN | BMY |
| Company | Alvotech | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 13.40 | 314.82 | 430.93 | 988.00 | 45.00 |
| High | 13.40 | 321.44 | 439.26 | 988.96 | 45.17 |
| Low | 13.29 | 312.87 | 428.62 | 966.34 | 44.54 |
| Last | 13.32 | 319.47 | 437.28 | 978.37 | 44.54 |
| Change | -0.03 | +8.06 | +8.69 | -6.27 | -0.17 |
| % Change | -0.22% | +2.59% | +2.03% | -0.64% | -0.38% |
| Volume | 22,769 | 1,737,378 | 490,132 | 337,000 | 5,133,843 |
| 20-Day Average Volume | 198,083 | 2,875,933 | 1,077,974 | 450,626 | 13,994,476 |
| Previous Close | 13.35 | 311.41 | 428.59 | 984.64 | 44.71 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 13.75 | 288.86 | 407.53 | 931.34 | 45.50 |
| 20-Day Raw Stochastic | 27.94% | 96.40% | 97.10% | 91.24% | 21.07% |
| 20-Day Relative Strength | 45.54% | 69.30% | 69.13% | 61.61% | 36.10% |
| Weighted Alpha | +54.42 | +43.69 | +30.14 | +30.25 | -33.00 |
| Today's Opinion | 24% Buy | 72% Buy | 56% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 24% Buy | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 8% Buy | 40% Sell | 24% Buy | 24% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.85% since 05/08/24 | +4.25% since 05/08/24 | +4.55% since 05/08/24 | +2.43% since 05/08/24 | +2.23% since 05/08/24 |
| Low | 13.22 on 05/13/24 | 306.32 on 05/09/24 | 416.03 on 05/09/24 | 956.76 on 05/09/24 | 43.49 on 05/09/24 |
| High | 13.72 on 05/10/24 | 321.44 on 05/15/24 | 439.26 on 05/15/24 | 988.96 on 05/15/24 | 45.72 on 05/14/24 |
| 1-Month | |||||
| %Chg | +6.32% since 04/15/24 | +20.66% since 04/15/24 | +10.19% since 04/15/24 | +8.95% since 04/15/24 | -7.97% since 04/15/24 |
| Low | 12.40 on 04/16/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 14.76 on 04/30/24 | 322.60 on 05/03/24 | 439.26 on 05/15/24 | 988.96 on 05/15/24 | 49.56 on 04/22/24 |
| 3-Month | |||||
| %Chg | -15.89% since 02/15/24 | +10.83% since 02/15/24 | +2.71% since 02/15/24 | +2.54% since 02/15/24 | -9.70% since 02/15/24 |
| Low | 11.01 on 04/02/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 18.00 on 02/26/24 | 322.60 on 05/03/24 | 439.26 on 05/15/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +45.56% since 11/15/23 | +17.34% since 11/15/23 | +25.34% since 11/15/23 | +23.55% since 11/15/23 | -13.43% since 11/15/23 |
| Low | 8.90 on 11/20/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 785.83 on 11/16/23 | 43.33 on 05/02/24 |
| High | 18.00 on 02/26/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 417,188 | 167,051,216 | 110,598,944 | 108,493,528 | 90,631,640 |
| Shares Outstanding, K | 31,250 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 91,430,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -551,730,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 18,900,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -276,560,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | -0.02 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.22 on 03/20/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/21/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.56 | 28.55 | 26.33 | 42.91 |